| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |